Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Sarcoma 1Other neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1Breast 1

Conditions

Thymoma 1Neoadjuvant Chemoimmunotherapy 1Myasthenia Gravis 1

Interventions

Carboplatin 347pembrolizumab 322Pemetrexed 246Cisplatin 218Paclitaxel 147Nivolumab 138durvalumab 133osimertinib 112Docetaxel 111atezolizumab 109Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 76Radiosurgery 72Gemcitabine 71Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 44Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Robotic Surgical Procedures × Thoracic × 1 year × Clear all
NCT07528066 2026-04-14

DRAGON-NSCLC

Shanghai Chest Hospital

Recruiting
200 enrolled
Thoracic

Neoadjuvant Chemoimmunotherapy

NCT05150210 2025-12-23

SP Thoracic IDE Study

Intuitive Surgical

Phase NA Active not recruiting
32 enrolled 8 charts
Thoracic

Myasthenia Gravis, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡